Bloodwork question about pramiracetam. Baseline, three weeks in, and the numbers moved in a direction I did not expect.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
Vivid dreams are reported widely and are not in the label because there is not really a label.
Anyone got a paper worth reading on this rather than a write-up of a paper?
Name the active ingredient, not just the brand. It makes these threads searchable years later.
How long before you can reasonably say something is or is not doing anything?
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
What is the first thing you would read if you were starting from zero?
Stupid question: how do you know whether what is in the vial matches the label at all? Three weeks in on pramiracetam and it lines up.
How long before you can reasonably say something is or is not doing anything?
Loose evidence is not nothing, but a washout either side is the only reason to trust your own take.
Is a baseline blood test really necessary before starting something like this? Not on pramiracetam but the pattern is familiar.
Baseline first.
What is the first thing you would read if you were starting from zero?
A plausible mechanism is not an outcome, and this class is the textbook example.